- The FDA has granted a second Breakthrough Device designation to CytoSorbents Corporation's CTSO DrugSorb-ATR Antithrombotic Removal System.
- The designation covers removing the Direct Oral Anticoagulants (DOACs) apixaban and rivaroxaban in a cardiopulmonary bypass circuit to reduce the likelihood of severe perioperative bleeding in cardiothoracic surgery.
- It follows the Breakthrough Designation received in April 2020 to remove ticagrelor for the same application.
- Apixaban (Eliquis, Bristol Myers Squibb & Co BMY / Pfizer Inc PFE) and rivaroxaban (Xarelto, Johnson & Johnson JNJ) are two of the most commonly prescribed anticoagulants.
- Based on CytoSorbents' estimates, at least 1% of patients in the U.S. on apixaban or rivaroxaban may require urgent cardiothoracic surgery on an annual basis.
- In July, the FDA signed off the STAR-T trial for ticagrelor removal during cardiothoracic surgery using CytoSorbents' DrugSorb ATR system.
- Price Action: CTSO shares are up 1.64% at $7.96 during the market session on the last check Thursday.
- Related content: Benzinga's Full FDA Calendar.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.